Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs

Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs

Background: Metformin use reportedly reduces cancer risk and improves survival in lung cancer patients. This study aimed to investigate the effect of metformin use in patients with diabetes mellitus (DM) and lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)...

Full description

Bibliographic Details
Main Authors:	Ming-Szu Hung MD, PhD, Min-Chun Chuang MD, Yi-Chuan Chen MD, Chuan-Pin Lee PhD, Tsung-Ming Yang MD, Pau-Chung Chen MD, PhD, Ying-Huang Tsai MD, Yao-Hsu Yang MD, PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-08-01
Series:	Integrative Cancer Therapies
Online Access:	https://doi.org/10.1177/1534735419869491

Similar Items

Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study
by: Chia-Ling Li MD, et al.
Published: (2019-02-01)

Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
by: Kei Kunimasa, MD, PhD, et al.
Published: (2020-03-01)

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
by: Kiichiro Ninomiya, MD, PhD, et al.
Published: (2021-01-01)

Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy
by: Katsuhiro Yoshimura, MD, et al.
Published: (2017-01-01)

Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in EGFR–Mutated Lung Cancer
by: Naoki Haratake, MD, PhD, et al.
Published: (2020-11-01)

Total knee arthroplasty for treatment of osteoarthritis with prolonged patellar dislocation
by: Kosuke Kumagai, MD, PhD, et al.
Published: (2017-03-01)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01)

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib
by: Atsushi Osoegawa, MD, PhD, et al.
Published: (2021-07-01)

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
by: Yuichiro Okumura, MD, et al.
Published: (2017-09-01)

Efficacy of Next-Generation EGFR-TKIs in Patients With Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
by: Yi-Tian Qi MM, et al.
Published: (2020-07-01)

The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study
by: Yuting Liu MD, et al.
Published: (2021-03-01)

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
by: Pedro E.N.S. Vasconcelos, MS, et al.
Published: (2020-09-01)

EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma
by: Chan Xiang, PhD, et al.
Published: (2021-07-01)

Hypothyroidism Could be a Potential Factor to Prolong Subcutaneous Nodules of Exenatide once Weekly: A Case Report
by: Ayako Ito, MD, et al.
Published: (2019-05-01)

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
by: Diego Enrico, MD, et al.
Published: (2020-06-01)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
by: Liping Zhuang MD, PhD, et al.
Published: (2020-11-01)

A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation
by: Masato Shimizu, MD, PhD, et al.
Published: (2016-09-01)

A Video Report of Brain–Lung–Thyroid Syndrome in a Japanese Female With a Novel Frameshift Mutation of the Gene
by: Takenori Tozawa MD, PhD, et al.
Published: (2016-08-01)

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
by: Tairo Kashihara, MD, PhD, et al.
Published: (2021-01-01)

Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients
by: Masato Katahira, MD, et al.
Published: (2020-06-01)

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
by: Kazuto Nishio, MD, PhD, et al.
Published: (2021-06-01)

Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline EGFR T790M Mutation
by: Netta Mäkinen, PhD, et al.
Published: (2021-04-01)

Afatinib as a Potential Therapeutic Option for Patients With NSCLC With EGFR G724S
by: Yang Wei, MD, et al.
Published: (2021-07-01)

Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules
by: Weizhi Chen MD, et al.
Published: (2019-01-01)

Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma
by: Atsushi Kagimoto, MD, et al.
Published: (2021-02-01)

Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations
by: Pedro E.N.S. Vasconcelos, MS, et al.
Published: (2021-03-01)

Hydroxychloroquine-Induced Toxic Myopathy Causing Diaphragmatic Weakness and Lung Collapse Requiring Prolonged Mechanical Ventilation
by: Julie Pillittere MD, et al.
Published: (2020-08-01)

Mast Cell Leukemia: Review of a Rare Disease and Case Report of Prolonged Survival after Allogeneic Stem Cell Transplant
by: James Bauer, MD, PhD, et al.
Published: (2017-11-01)

Smoking history and underlying lung disease are associated with poor outcome in patients developing interstitial pneumonia during low-dose amiodarone therapy
by: Masatsugu Nozoe, MD, PhD, et al.
Published: (2013-02-01)

Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation–Positive Lung Adenocarcinoma
by: Taehee Kim, M.D., et al.
Published: (2020-01-01)

Hypercalcemia Owing to Overproduction of 1,25-Dihydroxyvitamin D3 in Fetal Lung Adenocarcinoma: Case Report
by: Tomohito Saito, MD, PhD, et al.
Published: (2021-08-01)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
by: Naoko Kakuta, MD, et al.
Published: (2021-06-01)

Clinical Background and Evaluation of Drug-Induced Prolongation of QT Interval
by: Takao Katoh, MD, PhD
Published: (2009-01-01)

Free Flap Survival Despite Internal Jugular Vein Thrombosis in Head and Neck Reconstruction
by: Koichiro Kiya, MD, PhD, et al.
Published: (2018-01-01)

Acute limb ischemia of the lower extremity associated with left upper lobe surgery for primary lung cancer
by: Shigesato Inoue, MD, et al.
Published: (2018-06-01)

Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
by: Seung Sook Paik, M.D., et al.
Published: (2018-04-01)

Overexpressed HIF-2α in Endothelial Cells Promotes Vascularization and Improves Random Pattern Skin Flap Survival
by: Atsushi Morimoto, MD, et al.
Published: (2014-04-01)

Isolated endovascular repair of anomalous systemic arterial supply to the left basal lung
by: Kazufumi Suzuki, MD, et al.
Published: (2021-09-01)

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment
by: Mai Himedan MD, et al.
Published: (2017-09-01)

Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies
by: Seong Bok Jang, PhD, et al.
Published: (2021-10-01)